U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07846787) titled 'Control of Myopia in Young Children Using H.O.P.E. Lenses Combined With 0.02% Atropine Eye Drops' on Sept. 16.
Brief Summary: A multicenter, prospective, intervention study on the control of myopia in young children using high-order phase element array microstructure lenses (H.O.P.E.) in combination with low-concentration atropine eye drops (0.02%)
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Myopia
Intervention:
DEVICE: High-order Phase Element Array Microstructure Design Lens (H.O.P.E.)
Wear the H.O.P.E. lens frame glasses and use the placebo. Use it once per night for both eyes.
DRUG: 0.02% Atropine S...